PT1176976E - Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias. - Google Patents

Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias. Download PDF

Info

Publication number
PT1176976E
PT1176976E PT00927534T PT00927534T PT1176976E PT 1176976 E PT1176976 E PT 1176976E PT 00927534 T PT00927534 T PT 00927534T PT 00927534 T PT00927534 T PT 00927534T PT 1176976 E PT1176976 E PT 1176976E
Authority
PT
Portugal
Prior art keywords
hlh
day
follicles
fsh
placebo
Prior art date
Application number
PT00927534T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1176976(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of PT1176976E publication Critical patent/PT1176976E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00927534T 1999-05-07 2000-05-05 Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias. PT1176976E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07

Publications (1)

Publication Number Publication Date
PT1176976E true PT1176976E (pt) 2006-11-30

Family

ID=8241371

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00927534T PT1176976E (pt) 1999-05-07 2000-05-05 Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.

Country Status (18)

Country Link
US (2) US7695721B1 (de)
EP (1) EP1176976B2 (de)
JP (1) JP4975215B2 (de)
CN (1) CN1352566A (de)
AR (1) AR023869A1 (de)
AT (1) ATE332705T1 (de)
AU (1) AU4592800A (de)
BR (1) BR0010709B1 (de)
CA (1) CA2372714A1 (de)
DE (1) DE60029318T3 (de)
DK (1) DK1176976T4 (de)
ES (1) ES2267531T5 (de)
HK (1) HK1045261A1 (de)
IL (2) IL146252A0 (de)
PT (1) PT1176976E (de)
SI (1) SI1176976T2 (de)
TW (1) TWI242440B (de)
WO (1) WO2000067778A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1425033T1 (sl) * 2001-09-12 2011-01-31 Merck Serono Sa Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji
BR0212429A (pt) 2001-09-12 2004-10-26 Applied Research Systems Uso de hcg na hiperestimulação ovariana controlada
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
EP1434600B1 (de) * 2001-09-12 2009-04-08 Laboratoires Serono SA Verwendung von lh für die kontrollierte ovarielle hyperstimulation
EP1596881B1 (de) * 2003-02-07 2008-12-10 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
ES2414705T3 (es) * 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
WO2012042381A1 (en) 2010-09-29 2012-04-05 Ferring B.V. Composition for controlled ovarian stimulation
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
CA2842323A1 (en) 2011-07-18 2013-01-24 Arts Biologics A/S Long acting biologically active luteinizing hormone (lh) compound
US20150150497A1 (en) * 2012-07-18 2015-06-04 Mor Research Applications Ltd. Intrauterine device
WO2018080120A1 (en) * 2016-10-28 2018-05-03 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3d ultrasound images
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
AU770933B2 (en) * 1998-12-01 2004-03-11 N.V. Organon Improvement of folliculogenesis

Also Published As

Publication number Publication date
EP1176976B1 (de) 2006-07-12
EP1176976B2 (de) 2015-10-21
DE60029318T3 (de) 2016-03-10
BR0010709B1 (pt) 2011-11-29
DK1176976T3 (da) 2006-11-13
DE60029318D1 (de) 2006-08-24
AU4592800A (en) 2000-11-21
DE60029318T2 (de) 2007-08-09
US7151083B2 (en) 2006-12-19
TWI242440B (en) 2005-11-01
JP2002544168A (ja) 2002-12-24
CA2372714A1 (en) 2000-11-16
EP1176976A1 (de) 2002-02-06
ES2267531T3 (es) 2007-03-16
SI1176976T2 (sl) 2015-12-31
DE60029318T8 (de) 2007-11-22
AR023869A1 (es) 2002-09-04
SI1176976T1 (sl) 2006-10-31
US20040224895A1 (en) 2004-11-11
HK1045261A1 (zh) 2002-11-22
BR0010709A (pt) 2002-06-04
DK1176976T4 (en) 2015-11-02
JP4975215B2 (ja) 2012-07-11
ATE332705T1 (de) 2006-08-15
CN1352566A (zh) 2002-06-05
US7695721B1 (en) 2010-04-13
IL146252A0 (en) 2002-07-25
IL146252A (en) 2010-06-30
WO2000067778A1 (en) 2000-11-16
ES2267531T5 (es) 2015-11-24

Similar Documents

Publication Publication Date Title
PT1176976E (pt) Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.
Homburg et al. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.
Shoham et al. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone
JP2005501918A (ja) 制御下の過排卵刺激におけるｈＣＧの使用
WO1998058657A1 (en) Gonadotropin releasing hormone antagonist
PT723453E (pt) Metodo de tratamento de desordens reprodutoras
ES2356895T3 (es) USO DE LA hCG Y LH EN LA HIPERESTIMULACIÓN OVÁRICA CONTROLADA.
US7341989B2 (en) Use of LH in controlled ovarian hyperstimulation
ES2399962T3 (es) Método de hiperestimulación ovárica controlada y kit farmacéutico para uso en este método
AU2005202003B2 (en) Gonadotrophins
Neyro et al. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy
Nakamura et al. Clinical experience in the induction of ovulation and pregnancy with pulsatile subcutaneous administration of human menopausal gonadotropin: a low incidence of multiple pregnancy
MXPA01011208A (en) Gonadotrophins
Katznelson et al. Prolactin and its disorders
WO2023227761A1 (en) Compositions and methods for treatment of infertility in males
RU2201225C2 (ru) Способ лечения хронической ановуляции и профилактики синдрома гиперстимуляции яичников
Lidor et al. Combined somatostatin analog and follicle-stimulating hormone for women with polycystic ovary syndrome resistant to conventional treatment
Meridis et al. Drugs in reproductive medicine
Copperman et al. Induction of Monofolliculogenesis in Patients with Polycystic Ovary Syndrome
Miyakawa et al. A hyperprolactinemic woman with regular ovulatory menstrual cycles
Badawy Oral agents for ovulation induction: Old drugs revisited and new drugs re-evaluated
Duijkers et al. Hormonal serum profiles and follicular development after intramuscular and pulsatile intravenous administration of human menopausal gonadotrophin
Allahbadia et al. Urinary Gonadotropin Treatment in Patients with Polycystic Ovary Syndrome